Physician profile
Faisal Saeed
NPI 1598150674
$3,233.96
in general payments reported to CMS, 2019-2025
27 companies · $941 in 2025
The $941 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.21 · 2020: $62.85 · 2021: $34.03 · 2022: $317 · 2023: $813 · 2024: $1,008 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,677 · Education: $84.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,676.97 |
| Education | $84.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $422.22 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $374.20 | 2020-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $308.78 | 2023-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $259.13 | 2019-2025 | Watchman, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Novo Nordisk INC | $253.49 | 2024-2025 | Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $233.59 | 2022-2025 | Farxiga, Andexxa, Breztri |
| Amgen INC. | $222.74 | 2022-2025 | Repatha, Repatha |
| Abbott Laboratories | $189.21 | 2023-2024 | Confirm Rx, Jot Dx |
| Baxter Healthcare | $183.81 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $120.91 | 2023 | |
| Philips North America LLC | $107.20 | 2022-2024 | (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und |
| Novartis Pharmaceuticals Corporation | $72.34 | 2020-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $65.66 | 2024 | Arcalyst |
| Daiichi Sankyo INC. | $48.35 | 2023-2024 | Injectafer |
| Glaxosmithkline, LLC. | $46.49 | 2025 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.78 | 2020-2021 | |
| Inspire Medical Systems, INC. | $40.35 | 2024 | Inspire |
| Lilly USA, LLC | $39.80 | 2025 | Zepbound, Mounjaro |
| Lantheus Medical Imaging, INC. | $30.83 | 2019-2021 | |
| Medicomp INC | $29.40 | 2025 | Telepatch Cardiac Monitor |
| Kestra Medical Technology Services, INC. | $24.25 | 2023 | Assure Wcd |
| Medtronic, INC. | $24.09 | 2022 | |
| Edwards Lifesciences Corporation | $22.49 | 2019 | |
| Hologic Sales and Service, LLC | $21.65 | 2025 | Aptima |
| Dexcom, INC. | $17.92 | 2025 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $15.06 | 2022 | |
| Merck Sharp & Dohme LLC | $14.22 | 2024 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.